Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjogren's syndrome

被引:26
作者
Aqrawi, L. A. [1 ]
Skarstein, K. [2 ]
Oijordsbakken, G. [2 ]
Brokstad, K. A. [1 ]
机构
[1] Gade Inst, Broegelmann Res Lab, Bergen, Norway
[2] Gade Inst, Sect Pathol, Bergen, Norway
关键词
autoimmunity; B cells; Ro; SSA; salivary glands; Sjogren's syndrome; PERIPHERAL-BLOOD; BONE-MARROW; DEPRESSED PERCENTAGE; SOMATIC MUTATION; TARGET ORGAN; PLASMA-CELLS; MEMORY; AUTOANTIBODY; CD27; DIFFERENTIATION;
D O I
10.1111/cei.12058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary Sjogren's syndrome (pSS) is characterized by the presence of autoantibodies against the ribonucleoprotein (RNP) particles Ro/SSA and La/SSB, and mononuclear cell infiltration of exocrine tissues, especially salivary and lachrymal glands. Low numbers of autoantigen-specific memory B cells and elevated levels of plasma cells have been detected previously in the peripheral blood (PB) of pSS patients compared to controls. As both Ro52 and Ro60-specific cells have been detected in the salivary glands (SG) of pSS patients, we aimed to characterize the SSA-specific B cell pattern in SG biopsies. A series of double immunohistochemical stainings were performed on paraffin-embedded tissue from 10 well-characterized pSS patients for each Ro52 and Ro60 along with CD19, CD5, CD20 or CD27, respectively. Ro52 and Ro60-specific cells detected in SG tissue were found to be CD19+ B cells located outside the CD19+/CD20+ B cell zones (BCZ) and also interstitially. These SSA-specific cells were also quantified. No SSA-specific cells were CD5+, indicating that they do not belong to the B-1 B cell subset. Furthermore, no SSA-specific cells were observed within the CD20+ BCZ. Hence, no SSA-specific memory B cells were detected in these individuals. Contrary to this, SSA-specific cells were found to be CD19+/CD27++, demonstrating that they are differentiating short or long-lived plasma cells. Taken together, our findings suggest that these lower levels of SSA-specific memory B cells in PB and absence of SSA-specific memory B cells in SG of pSS patients could result from activation of these cells into plasma cells at the site of inflammation.
引用
收藏
页码:228 / 237
页数:10
相关论文
共 48 条
[1]   CD27: a memory B-cell marker [J].
Agematsu, K ;
Hokibara, S ;
Nagumo, H ;
Komiyama, A .
IMMUNOLOGY TODAY, 2000, 21 (05) :204-206
[2]   Reproducibility of biopsy grade in Sjogren's syndrome [J].
Al-Hashimi, I ;
Wright, JM ;
Cooley, CA ;
Nunn, ME .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2001, 30 (07) :408-412
[3]  
[Anonymous], CURR PROTOC IMMUNOL
[4]   Autoantigen-Specific Memory B Cells in Primary Sjogren's Syndrome [J].
Aqrawi, L. A. ;
Skarstein, K. ;
Bredholt, G. ;
Brun, J. G. ;
Brokstad, K. A. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (01) :61-68
[5]   Low number of memory B cells in the salivary glands of patients with primary Sjogren's syndrome [J].
Aqrawi, Lara A. ;
Brokstad, Karl A. ;
Jakobsen, Kjerstin ;
Jonsson, Roland ;
Skarstein, Kathrine .
AUTOIMMUNITY, 2012, 45 (07) :547-555
[6]  
Barcellos KSA, 2007, J RHEUMATOL, V34, P1283
[7]   Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration [J].
Bohnhorst, JO ;
Bjorgan, MB ;
Thoen, JE ;
Jonsson, R ;
Natvig, JB ;
Thompson, KM .
CLINICAL IMMUNOLOGY, 2002, 103 (01) :79-88
[8]   Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome [J].
Bohnhorst, JO ;
Bjorgan, MB ;
Thoen, JE ;
Natvig, JB ;
Thompson, KM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3610-3618
[9]   Significantly depressed percentage of CD27+(memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome [J].
Bohnhorst, JO ;
Thoen, JE ;
Natvig, JB ;
Thompson, KM .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (04) :421-427
[10]   B cell depletion therapy in systemic lupus erythematosus - Effect on autoantibody and antimicrobial antibody profiles [J].
Cambridge, G. ;
Leandro, M. J. ;
Teodorescu, M. ;
Manson, J. ;
Rahman, A. ;
Isenberg, D. A. ;
Edwards, J. C. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3612-3622